Both sides, in good faith

The strongest fair case each way — we don't pick a winner.

The case for

Supporters of the administration's stance argue that America's lead in AI is a fragile strategic asset that heavy-handed federal or state regulation could squander, handing dominance to China, which faces no such constraints. They contend that many voices calling loudest for regulation include large incumbent firms who stand to benefit from rules that raise costs and entrench their market position against smaller rivals, making scepticism of those motives reasonable rather than paranoid. On this view, innovation policy should prioritise speed and competitiveness, trusting existing oversight mechanisms and market pressures over new bureaucratic layers.

The case against

Critics argue that AI carries genuine, well-documented risks, from bias and misinformation to safety failures in high-stakes systems, and that dismissing calls for oversight as a foreign conspiracy sidesteps legitimate concerns raised by researchers, ethicists and even some industry leaders themselves. They contend that framing regulation purely as a China problem, or personalising safety around one leader's judgement, replaces careful policymaking with rhetoric and leaves the public without durable safeguards should political leadership change. For them, thoughtful, transparent regulation is compatible with maintaining competitiveness and is necessary to ensure AI development serves the public interest rather than only the interests of those building it.